Author:
Shapiro Daniel D.,Msaouel Pavlos
Reference10 articles.
1. Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade;Fitzgerald;Nat Rev Urol,2023
2. Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy;Ravaud;N Engl J Med,2016
3. Are we ready for adjuvant sunitinib in high-risk renal cell carcinoma?;Casuscelli;Eur Urol,2018
4. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial;Pal;Lancet North Am Ed,2022
5. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial;Motzer;Lancet North Am Ed,2023